tiprankstipranks
Advertisement
Advertisement
GH Research price target lowered to $65 from $70 at H.C. Wainwright
PremiumThe FlyGH Research price target lowered to $65 from $70 at H.C. Wainwright
22d ago
GH Research price target raised to $35 from $25 at Cantor Fitzgerald
Premium
The Fly
GH Research price target raised to $35 from $25 at Cantor Fitzgerald
26d ago
GH Research price target lowered to $39 from $42 at Citizens
Premium
The Fly
GH Research price target lowered to $39 from $42 at Citizens
26d ago
GH Research Posts Wider Q1 2026 Loss as R&D and Admin Costs Rise
PremiumCompany AnnouncementsGH Research Posts Wider Q1 2026 Loss as R&D and Admin Costs Rise
27d ago
GH Research Sets June 25, 2026 AGM and Tables Board, Auditor Votes
Premium
Company Announcements
GH Research Sets June 25, 2026 AGM and Tables Board, Auditor Votes
28d ago
GH Research to Attend APA Annual Meeting in San Francisco in May 2026
Premium
Company Announcements
GH Research to Attend APA Annual Meeting in San Francisco in May 2026
28d ago
Trump to sign order on psychedelic used for PTSD, CBS News says
PremiumThe FlyTrump to sign order on psychedelic used for PTSD, CBS News says
2M ago
Psychedelic: Compass Pathways, NRx Pharma report earnings results
Premium
The Fly
Psychedelic: Compass Pathways, NRx Pharma report earnings results
3M ago
GH Research Publishes Phase 2b GH001 TRD Data and Highlights Severity-Independent Efficacy
Premium
Company Announcements
GH Research Publishes Phase 2b GH001 TRD Data and Highlights Severity-Independent Efficacy
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100